Literature DB >> 18358071

Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia.

Wei Zhang1, Xiaobing Wang, Yi Liu, Haimei Tian, Brent Flickinger, Mark W Empie, Sam Z Sun.   

Abstract

A flaxseed lignan extract containing 33% secoisolariciresinol diglucoside (SDG) was evaluated for its ability to alleviate lower urinary tract symptoms (LUTS) in 87 subjects with benign prostatic hyperplasia (BPH). A randomized, double-blind, placebo-controlled clinical trial with repeated measurements was conducted over a 4-month period using treatment dosages of 0 (placebo), 300, or 600 mg/day SDG. After 4 months of treatment, 78 of the 87 subjects completed the study. For the 0, 300, and 600 mg/day SDG groups, respectively, the International Prostate Symptom Score (IPSS) decreased -3.67 +/- 1.56, -7.33 +/- 1.18, and -6.88 +/- 1.43 (mean +/- SE, P = .100, < .001, and < .001 compared to baseline), the Quality of Life score (QOL score) improved by -0.71 +/- 0.23, -1.48 +/- 0.24, and -1.75 +/- 0.25 (mean +/- SE, P = .163 and .012 compared to placebo and P = .103, < .001, and < .001 compared to baseline), and the number of subjects whose LUTS grade changed from "moderate/severe" to "mild" increased by three, six, and 10 (P = .188, .032, and .012 compared to baseline). Maximum urinary flows insignificantly increased 0.43 +/- 1.57, 1.86 +/- 1.08, and 2.7 +/- 1.93 mL/second (mean +/- SE, no statistical significance reached), and postvoiding urine volume decreased insignificantly by -29.4 +/- 20.46, -19.2 +/- 16.91, and -55.62 +/- 36.45 mL (mean +/- SE, no statistical significance reached). Plasma concentrations of secoisolariciresinol (SECO), enterodiol (ED), and enterolactone (EL) were significantly raised after the supplementation. The observed decreases in IPSS and QOL score were correlated with the concentrations of plasma total lignans, SECO, ED, and EL. In conclusion, dietary flaxseed lignan extract appreciably improves LUTS in BPH subjects, and the therapeutic efficacy appeared comparable to that of commonly used intervention agents of alpha1A-adrenoceptor blockers and 5alpha-reductase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358071     DOI: 10.1089/jmf.2007.602

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  16 in total

1.  Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.

Authors:  Li-Hua Chen; Jing Fang; Zhijian Sun; Huaixing Li; Ying Wu; Wendy Demark-Wahnefried; Xu Lin
Journal:  J Nutr       Date:  2009-02-11       Impact factor: 4.798

2.  Role of complimentary therapy for male LUTS.

Authors:  Philippa J Cheetham
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 3.  The effect of diet on BPH, LUTS and ED.

Authors:  Mahmoud ElJalby; Dominique Thomas; Dean Elterman; Bilal Chughtai
Journal:  World J Urol       Date:  2018-11-23       Impact factor: 4.226

4.  Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovaries.

Authors:  Anushka Dikshit; Chunqi Gao; Carrie Small; Karen Hales; Dale Buchanan Hales
Journal:  J Steroid Biochem Mol Biol       Date:  2016-02-27       Impact factor: 4.292

5.  Evidence of the Impact of Diet, Fluid Intake, Caffeine, Alcohol and Tobacco on Lower Urinary Tract Symptoms: A Systematic Review.

Authors:  Catherine S Bradley; Bradley A Erickson; Emily E Messersmith; Anne Pelletier-Cameron; H Henry Lai; Karl J Kreder; Claire C Yang; Robert M Merion; Tamara G Bavendam; Ziya Kirkali
Journal:  J Urol       Date:  2017-05-04       Impact factor: 7.450

6.  Flaxseed reduces epithelial proliferation but does not affect basal cells in induced benign prostatic hyperplasia in rats.

Authors:  Ilma Cely de Amorim Ribeiro; Carlos Alberto Soares da Costa; Vivian Alves Pereira da Silva; Lanna Beatriz Neves Silva Côrrea; Gilson Teles Boaventura; Mauricio Alves Chagas
Journal:  Eur J Nutr       Date:  2016-02-08       Impact factor: 5.614

7.  Fraction of macroporous resin from Smilax china L. inhibits testosterone propionate-induced prostatic hyperplasia in castrated rats.

Authors:  Jing Chen; Chao-Mei Xiong; Shan-Shan Song; Pan Han; Jin-Lan Ruan
Journal:  J Med Food       Date:  2012-04-17       Impact factor: 2.786

Review 8.  Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies?

Authors:  Chinedum Eleazu; Kate Eleazu; Winner Kalu
Journal:  Front Pharmacol       Date:  2017-04-28       Impact factor: 5.810

9.  Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia.

Authors:  Heeok Hong; Chun-Soo Kim; Sungho Maeng
Journal:  Nutr Res Pract       Date:  2009-12-31       Impact factor: 1.926

Review 10.  Potential protective properties of flax lignan secoisolariciresinol diglucoside.

Authors:  Muhammad Imran; Nazir Ahmad; Faqir Muhammad Anjum; Muhammad Kamran Khan; Zarina Mushtaq; Muhammad Nadeem; Shahzad Hussain
Journal:  Nutr J       Date:  2015-07-28       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.